Related Experiment Videos
[Adenyl cyclase activity of human blood platelets in various blood diseases]
Voprosy Meditsinskoi Khimii
|January 1, 1978
Insights
Adenyl cyclase activity significantly decreased in platelets of chronic myeloleukosis patients. This enzyme activity remained normal in osteomyelofibrosis and Glanzmann
Area of Science:
- Biochemistry
- Hematology
- Oncology
Context:
- Blood platelets play crucial roles in hemostasis and thrombosis.
- Adenyl cyclase is a key enzyme in cellular signaling pathways.
- Disruptions in platelet function are implicated in various hematological disorders.
Purpose:
- To investigate adenyl cyclase activity in blood platelets from patients with myeloleukosis, osteomyelofibrosis, and Glanzmann's thrombasthenia.
- To compare enzymatic activity in patient groups with healthy controls.
Summary:
- Adenyl cyclase activity was significantly reduced (six-fold decrease) in platelets from patients with chronic myeloleukosis.
- Platelet adenyl cyclase activity was comparable to healthy individuals in cases of osteomyelofibrosis and Glanzmann's thrombasthenia.
Impact:
- Findings suggest a specific biochemical alteration in chronic myeloleukosis.
- Highlights potential diagnostic or therapeutic targets related to adenyl cyclase in platelet disorders.
Abstract:
Adenyl cyclase activity was estimated in blood platelets of healthy persons and of patients with myeloleukosis, osteomyelofibrosis and with Glanzmann's thrombasthenia. Six-fold decrease in the adenyl cyclase activity from the platelets was observed in chronic myeloleukosis. The enzymatic activity in platelets was similar to normal level in osteomyelofibrosis and Glanzmann's thrombasthenia.